RelevantVapes.com was warned that its electronic nicotine delivery system (ENDS) products offered for sale on its website are tobacco products under FDA jurisdiction and must comply with the Federal Food, Drug, and Cosmetic Act. The company's products, which contain nicotine from any source, were found to lack the required premarket authorization orders necessary for legal marketing in the United States as "new tobacco products." The FDA determined that these ENDS products were being offered for distribution to U.S. customers without the mandated compliance with tobacco product regulations, including requirements established under the 2022 legislation that expanded FDA's regulatory authority to all nicotine-containing products regardless of their source.